13. Animal Models and Translational Medicine
Animal models for Alzheimer’s disease it is important to think about the human phenotype and what is being modeled in terms of the animal phenotype. The moderator, Bradley Hyman, professor of neurology at Harvard Medical School, said that animal models of Alzheimer’s disease, based on the genetics of the disease and the closely related frontotemporal dementia, replicate at least some of the pathology. Researchers have been successful at modeling very specific aspects of Alzheimer’s disease in the mouse (e.g., plaques, tangles). Although these are incomplete models of the human disease, they have been well received in the field as potentially relevant models for use in drug discovery.
Patients with Alzheimer’s disease will display both amyloidopathy and tauopathy; however, scientists often focus, in a reductionist way, on one or the other in an animal model.
This session includes Transgenic models, Pharmacological and lesion models, Natural and semi natural models, Primate models, Zebra fish models, Animal models of human cognitive aging, Development of new animal models, Genetics of translational models, Protein-protein interactions, Ethical issues with animal models.
Related Conference of 13. Animal Models and Translational Medicine
September 21-22, 2018
Dallas, Texas, USA
13. Animal Models and Translational Medicine Conference Speakers
- 1. Alzheimer’s disease and Dementia
- 10. Neurodegenerative Disease
- 11. Parkinson’s disease
- 12. Wernicke-Korsakoff Syndrome
- 13. Animal Models and Translational Medicine
- 14. Alzheimer’s disease Imaging
- 15. Alzheimer’s clinical trials and studies
- 2. Causes, Diagnosis and Symptoms
- 3. Care Practice and Awareness
- 4. Traumatic brain injury
- 5. Therapeutic Targets
- 6. Advances in lewy body dementia research
- 7. Neuropsychology and Neuropathology
- 8. Novel approaches in biomarkers
- 9. Vascular Dementia